Jeffrey M. Dayno - May 26, 2023 Form 4/A - Amendment Insider Report for Harmony Biosciences Holdings, Inc. (HRMY)

Role
PRESIDENT, CEO, Director
Signature
/s/ Christian Ulrich, Attorney-in-Fact
Stock symbol
HRMY
Transactions as of
May 26, 2023
Transactions value $
$0
Form type
4/A - Amendment
Date filed
5/31/2023, 04:37 PM
Date Of Original Report
May 30, 2023
Previous filing
Nov 4, 2022
Next filing
Jan 26, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRMY Stock Option Award $0 +125K $0.00 125K May 26, 2023 Common Stock 125K $35.56 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This Form 4/A is being filed to amend the exercise price of the granted options previously reported as being $35.99 to $35.56.
F2 The stock option vests with respect to 50% of the underlying shares on May 25, 2025, with the remaining shares vesting in twenty-four equal monthly installments beginning on June 25, 2025.